• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

ABCC2/MRP2 外排泵抑制剂的人类预测模型:定量构效关系研究。

Prediction model of human ABCC2/MRP2 efflux pump inhibitors: a QSAR study.

机构信息

Department of Medicinal Chemistry, Faculty of Pharmacy, University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh City, 700000, Vietnam.

School of Medicine, Vietnam National University Ho Chi Minh City, 700000, Ho Chi Minh City, Vietnam.

出版信息

Mol Divers. 2021 May;25(2):741-751. doi: 10.1007/s11030-020-10047-9. Epub 2020 Feb 11.

DOI:10.1007/s11030-020-10047-9
PMID:32048150
Abstract

The overexpression of ABCC2/MRP2, an ATP-binding cassette transporter, contributes to multidrug resistance in cancer cells. In this study, a quantitative structure-activity relationship (QSAR) analysis on ABCC2 inhibitors has been carried out, aiming to establish a computational prediction model for ABCC2 modulators. Seven classification models and two regression models were built by SONNIA 4.2, and two other regression models were built by MOE 2008.10 based on a data set comprising 372 compounds collected from 16 relevant publications. The CPG-C iABCC2 model for classifying ABCC2 inhibitors has total accuracy of 0.88 and Matthews correlation coefficient MCC = 0.75. The CPG-C iEG model for classifying ABCC2 inhibitors (substrate EG: β-estradiol 17-β-D-glucuronide) has total accuracy of 0.91 and MCC = 0.82. The regression model PLS EG-IC for predicting ABCC2 inhibitors (substrate EG) gave root-mean-square error RMSE = 0.26, Q = 0.73 and [Formula: see text]. The regression model PLS CDCF-IC for predicting ABCC2 inhibitors [substrate CDCF: 5(6)-carboxy-2',7'-dichlorofluorescein] gave RMSE = 0.31, Q = 0.74 and [Formula: see text]. Four 2D-QSAR models were applied to 1661 compounds, with results indicating 369 compounds having the ability to reverse the efflux of both EG and CDCF by ABCC2, 152 among them having IC < 100 µM.

摘要

ABCC2/MRP2 的过表达导致癌细胞的多药耐药。本研究对 ABCC2 抑制剂进行了定量构效关系(QSAR)分析,旨在建立 ABCC2 调节剂的计算预测模型。通过 SONNIA 4.2 构建了 7 个分类模型和 2 个回归模型,通过 MOE 2008.10 构建了另外 2 个回归模型,数据集由 16 篇相关文献中收集的 372 种化合物组成。CPG-C iABCC2 模型用于分类 ABCC2 抑制剂的总准确率为 0.88,马修斯相关系数 MCC=0.75。CPG-C iEG 模型用于分类 ABCC2 抑制剂(底物 EG:β-雌二醇 17-β-D-葡萄糖醛酸苷)的总准确率为 0.91,MCC=0.82。用于预测 ABCC2 抑制剂(底物 EG)的 PLS EG-IC 回归模型给出了 RMSE=0.26、Q=0.73 和 [Formula: see text]。用于预测 ABCC2 抑制剂[底物 CDCF:5(6)-羧基-2',7'-二氯荧光素]的 PLS CDCF-IC 回归模型给出了 RMSE=0.31、Q=0.74 和 [Formula: see text]。将四个 2D-QSAR 模型应用于 1661 种化合物,结果表明 369 种化合物具有逆转 ABCC2 对 EG 和 CDCF 外排的能力,其中 152 种化合物的 IC < 100 μM。

相似文献

1
Prediction model of human ABCC2/MRP2 efflux pump inhibitors: a QSAR study.ABCC2/MRP2 外排泵抑制剂的人类预测模型:定量构效关系研究。
Mol Divers. 2021 May;25(2):741-751. doi: 10.1007/s11030-020-10047-9. Epub 2020 Feb 11.
2
Exploring the structure-activity relationships of ABCC2 modulators using a screening approach.使用筛选方法探索ABCC2调节剂的构效关系。
Bioorg Med Chem. 2015 Jul 1;23(13):3513-25. doi: 10.1016/j.bmc.2015.04.029. Epub 2015 Apr 17.
3
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).预测和鉴定与人类ATP结合盒转运体多药耐药相关蛋白2(MRP2;ABCC2)的药物相互作用。
J Med Chem. 2008 Jun 12;51(11):3275-87. doi: 10.1021/jm7015683. Epub 2008 May 6.
4
Characterization of rhodamine-123, calcein and 5(6)-carboxy-2',7'-dichlorofluorescein (CDCF) export via MRP2 (ABCC2) in MES-SA and A549 cells.通过 MES-SA 和 A549 细胞中的 MRP2(ABCC2)对罗丹明 123、钙黄绿素和 5(6)-羧基-2',7'-二氯荧光素(CDCF)的外排进行表征。
Eur J Pharm Sci. 2011 Aug 17;43(5):359-69. doi: 10.1016/j.ejps.2011.05.003. Epub 2011 May 14.
5
Advancement of structure-activity relationship of multidrug resistance-associated protein 2 interactions.多药耐药相关蛋白2相互作用的构效关系研究进展。
AAPS J. 2009 Sep;11(3):406-13. doi: 10.1208/s12248-009-9117-0. Epub 2009 Jun 3.
6
In Vitro Transport Activity and Trafficking of MRP2/ABCC2 Polymorphic Variants.MRP2/ABCC2 多态性变异体的体外转运活性和转运。
Pharm Res. 2017 Aug;34(8):1637-1647. doi: 10.1007/s11095-017-2160-0. Epub 2017 Apr 12.
7
A structure-activity relationship study of ABCC2 inhibitors.ABCC2 抑制剂的构效关系研究
Eur J Pharm Sci. 2017 May 30;103:60-69. doi: 10.1016/j.ejps.2017.02.005. Epub 2017 Feb 7.
8
Interaction of eight HIV protease inhibitors with the canalicular efflux transporter ABCC2 (MRP2) in sandwich-cultured rat and human hepatocytes.八种 HIV 蛋白酶抑制剂在体外共培养的大鼠和人肝细胞中的胆小管分泌转运体 ABCC2(MRP2)的相互作用。
Biopharm Drug Dispos. 2010 Mar;31(2-3):178-88. doi: 10.1002/bdd.701.
9
Structure-activity relationships for interaction with multidrug resistance protein 2 (ABCC2/MRP2): the role of torsion angle for a series of biphenyl-substituted heterocycles.与多药耐药蛋白2(ABCC2/MRP2)相互作用的构效关系:一系列联苯取代杂环的扭转角作用
Drug Metab Dispos. 2007 Jun;35(6):937-45. doi: 10.1124/dmd.106.013250. Epub 2007 Mar 19.
10
A membrane vesicle-based assay to enable prediction of human biliary excretion.一种基于膜囊泡的检测方法,用于预测人体胆汁排泄。
Xenobiotica. 2013 Oct;43(10):915-9. doi: 10.3109/00498254.2013.769649. Epub 2013 Feb 12.

引用本文的文献

1
Identification of efflux pump inhibitors for Pseudomonas aeruginosa MexAB-OprM via ligand-based pharmacophores, 2D-QSAR, molecular docking, and molecular dynamics approaches.通过基于配体的药效团、二维定量构效关系、分子对接和分子动力学方法鉴定铜绿假单胞菌MexAB-OprM外排泵抑制剂
Mol Divers. 2024 Oct;28(5):3295-3311. doi: 10.1007/s11030-023-10758-9. Epub 2023 Nov 3.
2
Literature review and report of three cases of Dubin-Johnson syndrome related to ABCC2 gene mutations in children.儿童杜宾-约翰逊综合征与ABCC2基因突变相关的文献综述及三例病例报告
Am J Transl Res. 2021 May 15;13(5):4477-4488. eCollection 2021.

本文引用的文献

1
Emerging transporters of clinical importance: an update from the International Transporter Consortium.临床重要性新兴转运体:国际转运体联合会的最新进展。
Clin Pharmacol Ther. 2013 Jul;94(1):52-63. doi: 10.1038/clpt.2013.74. Epub 2013 Apr 8.
2
Impact of probe compound in MRP2 vesicular transport assays.MRP2 囊泡转运检测中探针化合物的影响。
Eur J Pharm Sci. 2012 May 12;46(1-2):100-5. doi: 10.1016/j.ejps.2012.02.016. Epub 2012 Mar 3.
3
Differential effect of P-gp and MRP2 on cellular translocation of gemifloxacin.P-糖蛋白和 MRP2 对吉米沙星细胞内转运的差异作用。
Int J Pharm. 2011 Nov 25;420(1):26-33. doi: 10.1016/j.ijpharm.2011.08.009. Epub 2011 Aug 16.
4
Counterpropagation networks.对向传播网络
Appl Opt. 1987 Dec 1;26(23):4979-83. doi: 10.1364/AO.26.004979.
5
Advancement of structure-activity relationship of multidrug resistance-associated protein 2 interactions.多药耐药相关蛋白2相互作用的构效关系研究进展。
AAPS J. 2009 Sep;11(3):406-13. doi: 10.1208/s12248-009-9117-0. Epub 2009 Jun 3.
6
The mechanism of ABC transporters: general lessons from structural and functional studies of an antigenic peptide transporter.ABC转运蛋白的机制:来自一种抗原肽转运蛋白结构与功能研究的一般经验教训。
FASEB J. 2009 May;23(5):1287-302. doi: 10.1096/fj.08-121855. Epub 2009 Jan 27.
7
Support vector machine and pharmacophore-based prediction models of multidrug-resistance protein 2 (MRP2) inhibitors.基于支持向量机和药效团的多药耐药蛋白2(MRP2)抑制剂预测模型
Eur J Pharm Sci. 2009 Mar 2;36(4-5):451-7. doi: 10.1016/j.ejps.2008.11.014. Epub 2008 Dec 11.
8
Classification models for HERG inhibitors by counter-propagation neural networks.基于反向传播神经网络的HERG抑制剂分类模型
Chem Biol Drug Des. 2008 Oct;72(4):279-89. doi: 10.1111/j.1747-0285.2008.00705.x.
9
A 4-aminobenzoic acid derivative as novel lead for selective inhibitors of multidrug resistance-associated proteins.
Bioorg Med Chem Lett. 2008 Sep 1;18(17):4761-3. doi: 10.1016/j.bmcl.2008.07.127. Epub 2008 Aug 3.
10
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).预测和鉴定与人类ATP结合盒转运体多药耐药相关蛋白2(MRP2;ABCC2)的药物相互作用。
J Med Chem. 2008 Jun 12;51(11):3275-87. doi: 10.1021/jm7015683. Epub 2008 May 6.